Visualitzant l d'Hebron Barcelona Hospital Campus

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Wainberg, Zev; Melisi, Davide; Pazo-Cid, Roberto A.; Chandana, Sreenivasa R; DE LA FOUCHARDIERE, CHRISTELLE; Macarulla, Teresa (Elsevier, 2023-10-07)

Nanoceria as Safe Contrast Agents for X-ray CT Imaging

García, Ana; Cámara Serrano, Juan Antonio; Mondragon Martinez, Laura; Franco Puntes, Victor; BOULLOSA GOBERNA, ANA MARIA; Freixanet Gusta, Muriel; Schwartz, Simo; Abasolo, Ibane (MDPI, 2023-07-29)

Nanoceria dissolution at acidic pH by breaking off the catalytic loop

Galyamin, Dmitry; Montaña Ernst, Lena Nerea; Fito Parera, Aina; Mira-Vidal, Guillem; Bastús, Neus G; Sabaté, Neus; Franco Puntes, Victor (Royal Society of Chemistry, 2022-10-06)

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Bekaii-Saab, Tanios S; Okusaka, Takuji; Goldstein, David; Ueno, Makoto; Ioka, Tatsuya; Tabernero Caturla, Josep; Oh, Do-Youn (Elsevier, 2023-04)

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea

Jurado Luque, Ma Jose; Quintana Luque, Manuel; Romero Santo-Tomas, Odile; Cambrodí i Masip, Roser; Ferré Masó, Alejandro; Sampol Sirvent, Julia; Sampol Rubio, Gabriel (Elsevier, 2022-11)

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

Cortellini, Alessio; Aguilar Company, Juan; Salazar, Ramón; Bower, Mark; Sita-Lumsden, Ailsa; Plaja, Andrea (Springer Nature, 2022-11-09)

Near-normal aerobic capacity in long-term survivors after lung transplantation

Saez Gimenez, Berta; Barrecheguren Fernández, Miriam; Ramon Belmonte, Maria Antonia; Gómez Garrido, Alba; Monforte Torres, Victor; Berastegui Garcia, Cristina; Revilla Lopez, Eva Maria; Román Broto, Antonio; Gómez Olles, Susana; Ojanguren Arranz, Iñigo; Romero Mesones, Christian Eduardo; López Meseguer, Manuel; Bravo Masgoret, Carles (European Respiratory Society, 2021-02-01)

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis

Fletcher Sanfeliu, Delfina; Millán Scheiding, Mónica; Primo-Romaguera, Vicent; Garcia Gausi, Maria; Pellino, Gianluca; Garcia-Granero, Alvaro (Springer, 2022-03)

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Zhu, Yinggang; Monsel, Antoine; Roberts, Jason A.; Pontikis, Konstantinos; Mimoz, Olivier; Rello Condomines, Jordi (MDPI, 2021-05-27)

Nefer, Sinuhe and clinical research assessing post COVID-19 condition

Waterer, Grant; Peñalvo, José L; Rello Condomines, Jordi; Soriano, Joan B (European Respiratory Society, 2021-04)

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Randon, Giovanni ; Nakamura, Yoshiaki; CREMOLINI, CHIARA; Yaeger, Rona; Lonardi, Sara; Elez, Elena; Ros, Javier (American Association for Cancer Research, 2024-01-15)

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

Pascual, Tomás; Antunes de Melo Oliveira, Ana Mafalda; Villagrasa, Patricia; Ortega Cebrian, Vanesa; Bermejo, Begoña; Nuciforo, Paolo Giovanni; Rubio Rodríguez, Isabel Teresa; Cortés Castan, Javier; Paré, Laia (Nature Research, 2021-11-25)

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Lopez-Bonet, Eugeni; Buxó, Maria; Cuyàs, Elisabet; Pernas, Sonia; Dorca, Joan; Álvarez, Isabel; Cortés Castan, Javier (MDPI, 2019-12-11)

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Figueras Coll, Marc; Fidalgo García, Andrea; Martí Aguascas, Gerard; Betrián Blasco, Pedro (Permanyer Publications, 2023)

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Marín Córdoba, Carlota; Camba, Fatima; Montaner Ramón, Alicia; Morey-Olivé, Miriam; RODO, CARLOTA; Arévalo Martínez, Silvia; Maiz, Nerea (Elsevier, 2024-02)

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model

Salas Torras, Anna; Badia Pérez, Anna; Fontrodona Montals, Laura; Zapata, Miguel Angel ; Garcia-Arumi, Jose; Duarri, Anna (MDPI, 2023-09-02)

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer

Lizakowski, Slawomir; Dębska-Ślizień, Maria Alicja; Kurnatowska, Ilona; Zaucha, Jan Maciej; Matuszewski, Marcin; Naumnik, Beata; Ferrandiz-Pulido, Carla (Polish Biochemical Society, 2023-05-09)

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Oaknin Benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10)

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Antunes de Melo Oliveira, Ana Mafalda; Feng, Yin-Hsun; Dai, Ming-Shen; Chen, Shang-Wen; Hurvitz, Sara; Saura Manich, Cristina (American Society of Clinical Oncology, 2020-09-20)

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Moy, Beverly; Antunes de Melo Oliveira, Ana Mafalda; Gradishar, William; Kim, Sung‑Bae; Brufsky, Adam; Saura Manich, Cristina (Oxford University Press, 2021-07)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant Vall d'Hebron Barcelona Hospital Campus - VH per títol

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Nanoceria as Safe Contrast Agents for X-ray CT Imaging

Nanoceria dissolution at acidic pH by breaking off the catalytic loop

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

Near-normal aerobic capacity in long-term survivors after lung transplantation

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Nefer, Sinuhe and clinical research assessing post COVID-19 condition

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant Vall d'Hebron Barcelona Hospital Campus - VH per títol

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial ﻿

Nanoceria as Safe Contrast Agents for X-ray CT Imaging ﻿

Nanoceria dissolution at acidic pH by breaking off the catalytic loop ﻿

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial ﻿

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea ﻿

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer ﻿

Near-normal aerobic capacity in long-term survivors after lung transplantation ﻿

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis ﻿

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives ﻿

Nefer, Sinuhe and clinical research assessing post COVID-19 condition ﻿

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study ﻿

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial ﻿

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer ﻿

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach ﻿

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center ﻿

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model ﻿

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer ﻿

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial ﻿

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial ﻿

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Nanoceria as Safe Contrast Agents for X-ray CT Imaging

Nanoceria dissolution at acidic pH by breaking off the catalytic loop

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

Near-normal aerobic capacity in long-term survivors after lung transplantation

“Near-TME”: proposed standardisation of the technique for proctectomy in male patients with ulcerative colitis

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Nefer, Sinuhe and clinical research assessing post COVID-19 condition

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

Neoadjuvant Metformin Added to Systemic Therapy Decreases the Proliferative Capacity of Residual Breast Cancer

Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach

Neonates with a prenatal diagnosis of hydrops fetalis: A 10-year experience in a tertiary care center

Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model

Nephro-oncology: clinical and biochemical aspects of kidney disease and cancer

Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens